Read more at CNBC.
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
Date: |
-
Financial Times - World
Novo Nordisk faces US Senate grilling over price of weight loss drugs
Senator Bernie Sanders accuses Ozempic and Wegovy maker of ‘ripping off’ AmericansYesterday -
MarketWatch - Business
Novo Nordisk CEO set to defend Ozempic, Wegovy prices on Capitol Hill
The CEO of Novo Nordisk is set to face pointed questions on Capitol Hill Tuesday about the prices of the Danish pharmaceutical giant’s blockbuster drugs Ozempic and Wegovy.21 minutes ago -
The Wall Street Journal - Business
The Price War in Weight-Loss Drugs Is Here
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.4 days ago -
NBC News - Top stories
Maker of Ozempic and Wegovy faces grilling over high cost of weight loss drugs
Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO is scheduled to testify on Capitol Hill Tuesday.4 hours ago -
The Hill - Politics
Novo CEO to blame drug middlemen
Presented by Prevent Cancer Foundation — The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss drugs Ozempic and Wegovy. ...15 hours ago -
CBS News - Top stories
Inside the thriving market for alternatives to brand-name weight loss drugs
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the meantime, a market for cheaper, compounded drugs thrives.3 days ago -
CBS News - Top stories
As weight loss drugs explode in popularity, are online marketplaces safe?
Weight loss drugs are exploding in popularity, with 1 in 8 Americans saying they have tried medications like Ozempic and Wegovy to tackle everything from diabetes to weight loss, among other ...2 days ago -
Financial Times - Business
US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
Complaint alleges pharmacy benefit managers owned by CVS, Cigna and UnitedHealth are keeping prices high3 days ago
More from CNBC
-
CNBC - Business
Fed Governor Bowman explains dissent on rate vote, says she's worried about inflation
No governor had dissented from an interest rate decision since 2005.22 minutes ago - Federal Reserve -
CNBC - Business
Blackstone and Vista Equity Partners to acquire software maker Smartsheet for $8.4 billion
The $8.4 billion deal is expected to close in January 2025, and the collaboration software maker has the option to solicit other bids.3 minutes ago -
CNBC - Business
JPMorgan CEO Jamie Dimon warns 'geopolitics is getting worse'
The JPMorgan Chase CEO said in an interview with CNBC-TV18 that his "caution is all geopolitics, which may determine the state of the economy."8 minutes ago -
CNBC - Business
Boeing sweetens labor proposal in 'best and final' offer as strike enters second week
The new offer includes higher pay raises, reinstated annual bonuses and an increased ratification bonus, among other changes, Boeing said on its website.13 minutes ago -
CNBC - Business
Biden's UN speech will highlight his diplomatic successes, amid wars in the Middle East, Ukraine, Sudan
The Biden administration is working towards a ceasefire and hostage deal in Gaza, even as the president's term comes to a close.4 hours ago - Joe Biden